Publications by authors named "Alice Labianca"

Claim this Profile
H
High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors.
Sara Manglaviti, Marta Bini, Giulia Apollonio, Ernesto Zecca, Giulia Galli, Alice Labianca

Lung Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program.
Arsela Prelaj, Achille Bottiglieri, Claudia Proto, Giuseppe Lo Russo, Diego Signorelli, Alice Labianca

Eur J Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicenter study of the Italian Melanoma Intergroup (IMI)" [Eur J Canc 137 (2020). Pages 30-39].
Mario Mandalà, Francesca Galli, Roberto Patuzzo, Andrea Maurichi, Simone Mocellin, Alice Labianca

Eur J Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study.
Piotr Rutkowski, Alice Indini, Matilde De Luca, Barbara Merelli, Anna Mariuk-Jarema, Alice Labianca

J Immunother Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy.
Pawel Teterycz, Anna M Czarnecka, Alice Indini, Mateusz J Spałek, Alice Labianca

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI).
Mario Mandalà, Francesca Galli, Roberto Patuzzo, Andrea Maurichi, Simone Mocellin, Alice Labianca

Eur J Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer.
Alice Labianca, Tommaso Bosetti, Alice Indini, Giorgia Negrini, Roberto Francesco Labianca

Cancers (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis